BioSyent Announces the Availability of Tibella® (tibolone) in Canada
29. Juli 2020 16:01 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, July 29, 2020 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) today announced the Canadian launch and product availability of Tibella® (tibolone)...
BioSyent Announces Health Canada Approval of New Women’s Health Product
13. Mai 2019 16:01 ET
|
BioSyent Inc.
TORONTO, May 13, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) announces that Health Canada has approved Tibella® (tibolone), indicated for the short-term...